News

Pharmabiz5h
Sebela Pharma announces positive results from phase 3 TRIUMpH programme of tegoprazan in GERD
Sebela Pharma announces positive results from phase 3 TRIUMpH programme of tegoprazan in GERD: Braintree, Massachusetts Friday, April 25, 2025, 18:00 Hrs [IST] Braintree Laborator ...
Pharmabiz6h
US FDA grants Breakthrough Device Designation to Mursla Bio’s EvoLiver test
US FDA grants Breakthrough Device Designation to Mursla Bio’s EvoLiver test: Cambridge, UK Friday, April 25, 2025, 17:00 Hrs [IST] Mursla Bio, a leader in Extracellular Vesicle ...
Pharmabiz7h
Breakthrough in bowel cancer research will speed up diagnosis
Breakthrough in bowel cancer research will speed up diagnosis: United Kingdom Friday, April 25, 2025, 16:00 Hrs [IST] Patients could soon benefit from world-leading technology to ...
Pharmabiz8h
NIH study reveals how inflammation makes touch painful
Researchers at the National Institutes of Health (NIH) have discovered clues as to how our bodies turn sensations such as heat and touch into signals sent to the brain — and how these signals can be ...
Pharmabiz8h
Philips launches new AI-enabled Elevate Platform upgrade on the EPIQ Elite ultrasound imaging platform
Philips launches new AI-enabled Elevate Platform upgrade on the EPIQ Elite ultrasound imaging platform: Our Bureau, Bengaluru Friday, April 25, 2025, 14:30 Hrs [IST] Royal Philips ...
Pharmabiz9h
Baebies receives US FDA breakthrough device designation for first point-of-care heparin monitoring test
Baebies receives US FDA breakthrough device designation for first point-of-care heparin monitoring test: Durham, North Carolina Friday, April 25, 2025, 14:00 Hrs [IST] Baebies, a ...
Pharmabiz9h
SS Innovations International, Inc., makers of SSI Mantra, gets listed on NASDAQ debut
SS Innovations International, Inc., makers of SSI Mantra, gets listed on NASDAQ debut: Our Bureau, Bengaluru Friday, April 25, 2025, 13:30 Hrs [IST] In a defining leap for Indian ...
Pharmabiz10h
New survey shows that over 90% of animal owners trust and appreciate veterinary teams but underestimate the demands of the profession
Ingelheim, Germany Friday, April 25, 2025, 13:00 Hrs [IST] ...
Pharmabiz11h
UK MHRA grants marketing authorisation to Biogen’s omaveloxolone to treat Friedreich’s ataxia
UK MHRA grants marketing authorisation to Biogen’s omaveloxolone to treat Friedreich’s ataxia: United Kingdom Friday, April 25, 2025, 12:00 Hrs [IST] The Medicines and Healthc ...
Pharmabiz12h
Increases in vaccine-preventable disease outbreaks threaten years of progress, warn WHO, UNICEF & Gavi
Increases in vaccine-preventable disease outbreaks threaten years of progress, warn WHO, UNICEF & Gavi: Geneva, Switzerland Friday, April 25, 2025, 11:00 Hrs [IST] Immunization ef ...
Pharmabiz13h
Pfizer advances bold vision for future of cancer care at the ASCO 2025 annual meeting
Pfizer advances bold vision for future of cancer care at the ASCO 2025 annual meeting: New York Friday, April 25, 2025, 10:00 Hrs [IST] Pfizer Inc. will showcase data across its p ...
Pharmabiz14h
Daiichi Sankyo seeks Japanese approval for Enhertu to treat patients with HER2 positive metastatic solid tumours
Daiichi Sankyo seeks Japanese approval for Enhertu to treat patients with HER2 positive metastatic solid tumours: Tokyo Friday, April 25, 2025, 09:00 Hrs [IST] Daiichi Sankyo has ...